Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason T Kimata

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Biorxiv : the Preprint Server for Biology|July 16, 2021
Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concernJeroen Pollet, Ulrich Strych, Wen-Hsiang Chen, et al.
Vaccines|October 28, 2023
A Recombinant Protein XBB.1.5 RBD/Alum/CpG Vaccine Elicits High Neutralizing Antibody Titers against Omicron Subvariants of SARS-CoV-2Syamala Rani Thimmiraju, Rakesh Adhikari, Maria Jose Villar, et al.
Science Translational Medicine|June 28, 2023
Long-acting refillable nanofluidic implant confers protection against SHIV infection in nonhuman primatesFernanda P Pons-Faudoa, Nicola Di Trani, Simone Capuani, et al.
Frontiers in Immunology|October 25, 2021
Serum IgG anti-SARS-CoV-2 Binding Antibody Level Is Strongly Associated With IgA and Functional Antibody Levels in Adults Infected With SARS-CoV-2Xunyan Ye, Laura S Angelo, Erin G Nicholson, et al.
Advanced Therapeutics|May 17, 2021
Preventive efficacy of a tenofovir alafenamide fumarate nanofluidic implant in SHIV-challenged nonhuman primatesFernanda P Pons-Faudoa, Antons Sizovs, Kathryn A Shelton, et al.
Expert Review of Vaccines|May 30, 2023
From concept to delivery: a yeast-expressed recombinant protein-based COVID-19 vaccine technology suitable for global accessPeter J Hotez, Rakesh Adhikari, Wen-Hsiang Chen, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Biorxiv : the Preprint Server for Biology|July 16, 2021
Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concernJeroen Pollet, Ulrich Strych, Wen-Hsiang Chen, et al.
Vaccines|October 28, 2023
A Recombinant Protein XBB.1.5 RBD/Alum/CpG Vaccine Elicits High Neutralizing Antibody Titers against Omicron Subvariants of SARS-CoV-2Syamala Rani Thimmiraju, Rakesh Adhikari, Maria Jose Villar, et al.
Science Translational Medicine|June 28, 2023
Long-acting refillable nanofluidic implant confers protection against SHIV infection in nonhuman primatesFernanda P Pons-Faudoa, Nicola Di Trani, Simone Capuani, et al.
Frontiers in Immunology|October 25, 2021
Serum IgG anti-SARS-CoV-2 Binding Antibody Level Is Strongly Associated With IgA and Functional Antibody Levels in Adults Infected With SARS-CoV-2Xunyan Ye, Laura S Angelo, Erin G Nicholson, et al.
Advanced Therapeutics|May 17, 2021
Preventive efficacy of a tenofovir alafenamide fumarate nanofluidic implant in SHIV-challenged nonhuman primatesFernanda P Pons-Faudoa, Antons Sizovs, Kathryn A Shelton, et al.
Expert Review of Vaccines|May 30, 2023
From concept to delivery: a yeast-expressed recombinant protein-based COVID-19 vaccine technology suitable for global accessPeter J Hotez, Rakesh Adhikari, Wen-Hsiang Chen, et al.
Pageof 8